W. Becker, L. Sullivan, J. Tetrault, R. Desai, and D. Fiellin, Non-medical use, abuse and dependence on prescription opioids among U.S. adults: Psychiatric, medical and substance use correlates, Drug and Alcohol Dependence, vol.94, issue.1-3, pp.1-338, 2008.
DOI : 10.1016/j.drugalcdep.2007.09.018

J. Carlin, R. Wolfe, C. Coffey, and G. Patton, Survival Models: Analysis of Binary Outcomes in Longitudinal Studies Using Weighted Estimating Equations and Discrete-Time Survival Methods: Prevalence and Incidence of Smoking in An Adolescent Cohort, Stat Med, vol.18, pp.2655-2679, 1999.
DOI : 10.1002/0470023678.ch1d(ii)

M. Carrieri, L. Amass, G. Lucas, D. Vlahov, A. Wodak et al., Buprenorphine Use: The International Experience, Clinical Infectious Diseases, vol.43, issue.Supplement 4, pp.197-215, 2006.
DOI : 10.1086/508184

T. Cicero, J. Inciardi, and A. Munoz, Trends in Abuse of OxyContin?? and Other Opioid Analgesics in the United States: 2002-2004, The Journal of Pain, vol.6, issue.10, pp.662-672, 2005.
DOI : 10.1016/j.jpain.2005.05.004

A. Dahan, Opioid-induced respiratory effects: new data on buprenorphine, Palliative medicine, vol.20, issue.1, pp.3-8, 2006.

A. Gilson, The Concept of Addiction in Law and Regulatory Policy Related to Pain Management, The Clinical Journal of Pain, vol.26, issue.1, pp.70-77, 2010.
DOI : 10.1097/AJP.0b013e3181b12a2d

A. Gilson and P. Kreis, The Burden of the Nonmedical Use of Prescription Opioid Analgesics, Pain Medicine, vol.10, issue.suppl 2, pp.89-100, 2009.
DOI : 10.1111/j.1526-4637.2009.00668.x

M. Gossop, The development of a short opiate withdrawal scale (SOWS), Addictive Behaviors, vol.15, issue.5, pp.487-490, 1990.
DOI : 10.1016/0306-4603(90)90036-W

T. Green, L. Grau, H. Carver, M. Kinzly, and R. Heimer, Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997???2007, Drug and Alcohol Dependence, vol.115, issue.3, pp.221-228, 2011.
DOI : 10.1016/j.drugalcdep.2010.11.007

A. Hall, J. Logan, R. Toblin, J. Kaplan, J. Kraner et al., Patterns of Abuse Among Unintentional Pharmaceutical Overdose Fatalities, JAMA, vol.300, issue.22, pp.2613-2620, 2008.
DOI : 10.1001/jama.2008.802

C. Huxtable, L. Roberts, A. Somogyi, and P. Macintyre, Acute pain management in opioid-tolerant patients: a growing challenge, Anaesth Intensive Care, vol.39, issue.5, pp.804-823, 2011.

M. Jalili, M. Fathi, M. Moradi-lakeh, and S. Zehtabchi, Sublingual Buprenorphine in Acute Pain Management: A Double-Blind Randomized Clinical Trial, Annals of Emergency Medicine, vol.59, issue.4, pp.276-280, 2011.
DOI : 10.1016/j.annemergmed.2011.10.021

D. Jasinski, J. Pevnick, and J. Griffith, Human Pharmacology and Abuse Potential of the Analgesic Buprenorphine, Archives of General Psychiatry, vol.35, issue.4, pp.501-516, 1978.
DOI : 10.1001/archpsyc.1978.01770280111012

R. Johnson, M. Chutuape, E. Strain, S. Walsh, M. Stitzer et al., A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence, New England Journal of Medicine, vol.343, issue.18, pp.1290-1297, 2000.
DOI : 10.1056/NEJM200011023431802

R. Johnson, P. Fudala, and R. Payne, Buprenorphine: Considerations for Pain Management, Journal of Pain and Symptom Management, vol.29, issue.3, pp.297-326, 2005.
DOI : 10.1016/j.jpainsymman.2004.07.005

J. Jones, M. Sullivan, J. Manubay, S. Vosburg, and S. Comer, The Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Patients with Chronic, Non-Malignant Pain who are Maintained on Sublingual Buprenorphine/Naloxone, Neuropsychopharmacology, vol.42, issue.2, pp.411-422, 2011.
DOI : 10.1038/npp.2010.172

M. Kahan, A. Srivastava, A. Ordean, and S. Cirone, Buprenorphine: new treatment of opioid addiction in primary care, Can Fam Physician, vol.57, issue.3, pp.281-289, 2011.

M. Kahan, L. Wilson, A. Mailis-gagnon, and A. Srivastava, Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations, Can Fam Physician, vol.57, issue.11, pp.1269-1276, 2011.

C. Keller, L. Ashrafioun, A. Neumann, J. Van-klein, C. Fox et al., Practices, Perceptions, and Concerns of Primary Care Physicians About Opioid Dependence Associated with the Treatment of Chronic Pain, Substance Abuse, vol.7, issue.2, pp.103-113, 2012.
DOI : 10.1001/jama.2011.401

N. Khosla, H. Juon, G. Kirk, J. Astemborski, and S. Mehta, Correlates of non-medical prescription drug use among a cohort of injection drug users in Baltimore City, Addictive Behaviors, vol.36, issue.12, pp.1282-1287, 2011.
DOI : 10.1016/j.addbeh.2011.07.046

B. Kogel, C. T. Strassburger, W. Friderichs, and E. , Interaction of ??-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice, European Journal of Pain, vol.16, issue.6, pp.599-611, 2005.
DOI : 10.1016/j.ejpain.2005.02.002

W. Ling, L. Mooney, and M. Hillhouse, Prescription opioid abuse, pain and addiction: Clinical issues and implications, Drug and Alcohol Review, vol.13, issue.1, pp.300-305, 2011.
DOI : 10.1111/j.1465-3362.2010.00271.x

W. Ling, D. Wesson, C. Charuvastra, and C. Klett, A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence, Archives of General Psychiatry, vol.53, issue.5, pp.401-407, 1996.
DOI : 10.1001/archpsyc.1996.01830050035005

L. Manchikanti, B. Fellows, H. Ailinani, and V. Pampati, Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective, Pain Physician, vol.13, issue.5, pp.401-435, 2010.

R. Melzack, The short-form McGill pain questionnaire, Pain, vol.30, issue.2, pp.191-197, 1987.
DOI : 10.1016/0304-3959(87)91074-8

B. Naliboff, S. Wu, B. Schieffer, R. Bolus, Q. Pham et al., A Randomized Trial of 2 Prescription Strategies for Opioid Treatment of Chronic Nonmalignant Pain, The Journal of Pain, vol.12, issue.2, pp.288-296, 2011.
DOI : 10.1016/j.jpain.2010.09.003

P. Pade, K. Cardon, R. Hoffman, and C. Geppert, Prescription opioid abuse, chronic pain, and primary care: A Co-Occurring Disorders Clinic in the chronic disease model, Journal of Substance Abuse Treatment, vol.43, issue.4, 2012.
DOI : 10.1016/j.jsat.2012.08.010

J. Pergolizzi, J. Gharibo, C. Passik, S. Labhsetwar, S. Taylor et al., Dynamic risk factors in the misuse of opioid analgesics, Journal of Psychosomatic Research, vol.72, issue.6, pp.443-451, 2012.
DOI : 10.1016/j.jpsychores.2012.02.009

R. Poyhia, A. Vainio, and E. Kalso, A review of oxycodone's clinical pharmacokinetics and pharmacodynamics, Journal of Pain and Symptom Management, vol.8, issue.2, pp.63-67, 1993.
DOI : 10.1016/0885-3924(93)90101-Z

S. Ripa, B. Mccarberg, C. Munera, W. Wen, and C. Landau, A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 ??g/h or 20 ??g/h in patients with osteoarthritis pain, Expert Opinion on Pharmacotherapy, vol.31, issue.2, pp.1229-1241, 2012.
DOI : 10.1007/s12325-009-0075-9

P. Roux, P. Carrieri, J. Cohen, I. Ravaux, B. Spire et al., Non-medical use of opioids among HIV-infected opioid dependent individuals on opioid maintenance treatment: the need for a more comprehensive approach, Harm Reduction Journal, vol.8, issue.1, p.31, 2011.
DOI : 10.1186/1477-7517-8-31

URL : https://hal.archives-ouvertes.fr/inserm-00674029

A. Silversides, Use of strong opioids in Canada rose sharply between 2005 and 2010, BMJ, vol.343, issue.aug25 2, p.5441, 2005.
DOI : 10.1136/bmj.d5441

D. Steiner, S. Sitar, W. Wen, G. Sawyerr, C. Munera et al., Efficacy and Safety of the Seven-Day Buprenorphine Transdermal System in Opioid-Na??ve Patients with Moderate to Severe Chronic Low Back Pain: An Enriched, Randomized, Double-Blind, Placebo-Controlled Study, Journal of Pain and Symptom Management, vol.42, issue.6, pp.903-917, 2011.
DOI : 10.1016/j.jpainsymman.2011.04.006

C. Townsend, J. Kerkvliet, B. Bruce, J. Rome, W. Hooten et al., A longitudinal study of the efficacy of a comprehensive pain rehabilitation program with opioid withdrawal: Comparison of treatment outcomes based on opioid use status at admission, Pain, vol.140, issue.1, pp.177-189, 2008.
DOI : 10.1016/j.pain.2008.08.005

D. Turk, O. Connor, A. Dworkin, R. Chaudhry, A. Katz et al., Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations, Pain, vol.153, issue.10, pp.1997-2008, 2012.
DOI : 10.1016/j.pain.2012.05.029

K. Vowles and J. Ashworth, Is opioid withdrawal necessary within comprehensive pain rehabilitation programs?, Pain, vol.152, issue.9, pp.1948-1950, 2011.
DOI : 10.1016/j.pain.2011.03.016

D. Wesson and D. Smith, Buprenorphine in the Treatment of Opiate Dependence, Journal of Psychoactive Drugs, vol.274, issue.2, pp.161-175, 2010.
DOI : 10.1016/j.dld.2007.12.014

M. Wolfert, A. Gilson, J. Dahl, and J. Cleary, Opioid Analgesics for Pain Control: Wisconsin Physicians' Knowledge, Beliefs, Attitudes, and Prescribing Practices, Pain Medicine, vol.11, issue.3, pp.425-434, 2010.
DOI : 10.1111/j.1526-4637.2009.00761.x

S. Zeger and K. Liang, Longitudinal Data Analysis for Discrete and Continuous Outcomes, Biometrics, vol.42, issue.1, pp.121-130, 1986.
DOI : 10.2307/2531248